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1. Introduction
About 150 species belong to the Mycobacterium genus and are known as acid-fast bacillus. 
These bacteria are widely distributed in different ecosystems and it can be isolated from water, 
soil, or air. The Mycobacterium genus has a great metabolic diversity that has allowed them 
to adapt and survive in almost all environmental conditions. They are called slow-growing 
bacteria, because of their long generation times in comparison with other bacterial genus. 
Currently, there are new species which are being studied in order to be classified as new 
members of the Mycobacterium genus.
Some species of the Mycobacterium genus are known as nontuberculous mycobacteria (NTM). 
It can cause the mycobacteriosis disease in humans or animals. At present, it has not been 
established that mycobacteriosis is transmitted from person to person. This is one of the 
causes for not knowing precisely the number of cases of this disease and difficulties for an 
opportune diagnosis. The severity of the disease caused by NTM depends on multiple factors, 
the most relevant being the condition of the individual’s immune system, the virulence char-
acteristics of these bacteria, and the amount of NTM that is transmitted to the infected host. In 
the field of scientific research, there are studies on different aspects related to these microor-
ganisms, nevertheless many characteristics of NTM and their implications in environmental 
processes, health or industrial use are not known in which given their great metabolic variety 
can help to solve environmental problems that threaten the human and animal’s health and 
that compromise the quality of life of future generations.
Tuberculosis is an infectious disease caused by bacteria belonging to the Mycobacterium 
tuberculosis complex. Tuberculosis was declared a global emergency by the World Health 
Organization and it is considered a serious public health problem worldwide, given that it is 
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one of the infectious diseases that causes the most deaths worldwide along with the human 
immunodeficiency virus (HIV). Despite the strategies and efforts to achieve its control, the 
situation of tuberculosis is worrying and it is considered in several countries as an event of 
interest in public health. Therefore, the control implemented by each country is of vital impor-
tance to cut the chain of transmission. The foregoing evidences the priority need to conduct 
research on factors associated with tuberculosis control while continuing to produce new 
information in all areas of knowledge that may contribute to tuberculosis control.
Leprosy is a chronic disease, known as a peripheral neuropathy that can produce several and 
irreversible sequelae observed in the patient who has suffered from this disease, and as a con-
sequence, it has generated a great stigma for all patients. Leprosy is an ancestral disease and 
has also been known as Hansen’s disease, and there are currently studies documenting the 
great social and cultural component involved in the worldwide transmission and persistence 
of this infectious disease. The World Health Organization has declared leprosy as a disease 
in elimination due to the number of reported cases of patients, but there are countries that 
still report a recent transmission of the disease and in some of its provinces a larger number is 
diagnosed. A number of cases estimated by the World Health Organization consider that this 
country has reached the goal of elimination. M. leprae, the causative agent of leprosy, is not a 
cultivable microorganism in synthetic culture media, causing the diagnosis of the disease to 
be basically clinical even though there are currently molecular methodologies that can make 
an opportune diagnosis of the disease before the disability is observable in each individual 
affected by this alcohol-resistant acid bacillus.
The scientific research done on the species belonging to Mycobacterium genus can be classified 
into three groups. The following graph shows that a large number of publications in scientific 
research related to tuberculosis, leprosy, and some mycobacteriosis are produced. In the envi-
ronmental field or application of mycobacteria to industrial processes, a smaller amount of 
new knowledge is produced that is useful for contribution to solving problems that threaten 
humanity but something very important is the little evidence generated by evaluation proj-
ects that must be carried out on the processes implemented in each country or region of the 
world so that the effect achieved can be attributed to the measure or knowledge implemented 
(Figure 1).
Given that tuberculosis, leprosy, and mycobacteria are diseases that affect a large population 
worldwide, control programs are performed in the regulatory framework of each country, 
and it is necessary and urgent that there is solid and incontrovertible evidence its impact and 
management in the control of these diseases that affect all individuals of different ages, gen-
ders, and social strata of a community, being of great importance the performance of periodic 
evaluations of the measures implemented by each government against the knowledge gener-
ated by the scientific investigation.
The evaluation of the projects, plans, policies, and strategies implemented must include the 
commitment of the authorities of each country and of the different territorial entities, in order 
to determine the effectiveness, cost-effectiveness, and attributions of the results obtained to 
the extent implemented in the community or country. These scientific evaluation projects 
should be based on official data collected through the information and monitoring system 
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of territorial entities for the measurement of performance and evaluation of the measures 
implemented. These evaluation projects make it possible to demonstrate the changes gener-
ated from the implementation of national or international policies, but especially should be 
evidence for decision-making and recommendations in health, public health, and interna-
tional health.
One of the main limitations for the realization of scientific evaluation projects is to attribute 
the observed effect to the intervention implemented and evaluated. Because many of the pro-
cesses in health, public health, or global health are assumed by the state governments through 
their national control programs, all control and surveillance activities must be authorized, 
assumed, and monitored by these control programs. Therefore, significant variations are only 
possible because of the implemented measures of an official nature or the sociocultural and 
political situation of each country that in any way affects the epidemiological situation of 
the disease independent of the adoption of measures or plans. In scientific research projects, 
many of the studies are conducted in environments and under highly controlled conditions 
and obtain reasonable cost-effectiveness levels, contrary to the result obtained in some situa-
tions on the costs that are required to reach the same level in the programmatic conditions of 
each country, requiring a large amount of human resources, infrastructure, and inputs that 
make the measure provided is not feasible to implement.
The great diversity of environments and social, cultural, and environmental determinants, 
scientific research and its evaluation in the species that make up the Mycobacterium genus, also 
presents the difficulty that its results and knowledge generated are representative for a com-
munity and applicable to other regions of the world. world that are similar in their conditions, 
it is almost imperative that each region or country performs its own evaluation processes to 
obtain evidence before implementing new control measures in their communities, complying 
with the provisions of the ethical considerations that shelter the population in the safekeeping 
of their human rights and a healthy environment.
Figure 1. Research and scientific evaluation in mycobacteria.
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The information obtained in the research and evaluation projects in the Mycobacterium genus 
should provide in the medium and long term that the results obtained contribute to the con-
struction of new policies for the management and control of the disease, should serve as a 
critical input for the construction once again, knowledge must allow the evidence obtained to 
be able to reformulate or propose the operation of the indicators in time, form, and recourse. 
They should strengthen and contribute new knowledge in public health research and in the 
evaluation of broad coverage health programs.
The results of the research and evaluation projects must be translated into a language that is 
comprehensible to all through support provided by communicators with experience in health, 
politics, the environment, and the general community, who must objectively and appropri-
ately carry out the adjustment of the vocabulary for dissemination in press, radio, television, 
and the general population.
The information must be widely disseminated and at all levels as illustrated in Figure 2.
The results obtained should be released to the community and the media in full report in large 
print and digital form, preferably with a slide presentation and a written guide to the presenta-
tion, to facilitate the management of information at management meetings and decision-making to 
finance new research or scientific evaluation projects, which leads to objective planning and deci-
sion-making based on the results of a rigorous scientific research or evaluation that will benefit the 
community and the different groups of policy-makers, decisions, and generators of knowledge.
2. Conclusion
This panorama and epidemiological record shows the difficult situation that is experienced 
worldwide against transmission, morbidity, and mortality caused by mycobacteria, and 
Figure 2. Flow of results of research and evaluation projects in mycobacteria.
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despite the strategies and efforts made by different countries through their national control 
programs, the situation has a high impact on the world economy. Therefore, the control car-
ried out by each country is of vital importance to cut the chain of transmission, requiring that 
operational research be prioritized and evaluations be made of the measures, plans, and poli-
cies implemented by each country to successfully advance in its control. It is also necessary to 
carry out scientific research on the species that make up the Mycobacterium genus to know the 
metabolic characteristics that allow its application in the process of great benefit for industry, 
health, and the environment.
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